or Try an Advanced Search...

    Refractory Solid Tumors Stocks List

    Symbol Grade Name % Change
    MEIP D MEI Pharma, Inc. 0.65
    CRIS F Curis, Inc. -1.20
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Solid Tumors Advanced Non Small Cell Lung Cancer Breast Cancer Cancer Cell Cancer Therapeutics Carcinoma Clinical Development Clinical Medicine Drug Discovery Drugs Hematological Cancers Histone Deacetylase Inhibitor Lung Cancer Lymphoma Medicine Multiple Myeloma Non Small Cell Lung Cancer Novogen Phosphoinositide 3 Kinase Inhibitor

    Related ETFs - A few ETFs which own one or more of the above listed Refractory Solid Tumors stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.01
    View all Refractory Solid Tumors ETFs...
    Compare ETFs

        Refractory Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 2 CRIS Curis price target lowered to $20 from $26 at H.C. Wainwright
        Oct 29 CRIS Curis looks to raise $12.1M in private placement
        Oct 29 CRIS Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Solid Tumors Advanced Non Small Cell Lung Cancer Breast Cancer Cancer Cell Cancer Therapeutics Carcinoma Clinical Development Clinical Medicine Drug Discovery Drugs Hematological Cancers Histone Deacetylase Inhibitor Lung Cancer Lymphoma Medicine Multiple Myeloma Non Small Cell Lung Cancer Novogen Phosphoinositide 3 Kinase Inhibitor
        Refractory Solid Tumors

        Refractory solid tumors are solid tumors that are resistant to standard treatments such as chemotherapy, radiation, and surgery. These tumors are often difficult to treat and may require more aggressive treatments such as targeted therapies or immunotherapies.

        Browse All Tags